A generational advance in the treatment of vertebral compression fractures

The following is a Sponsored Resource. The sponsor of this content has sole editorial control.


Physicians

A generational advance in the treatment of vertebral compression fractures

StabitT Video

Unprecedented control over access, navigation, cement delivery, and radiation exposure in the treatment of VCF’s.

  • Vertebral access and cavity creation control
    • Unipedicular access to vertebrae*
    • Targeted cavity creation across the vertebral midline
    • Preferential pathways for high viscosity StabiliT Bone Cement to follow
  • Controlled bone cement delivery rate to maximize interdigitation and fracture stability
  • Remotely-controlled hand-switch minimizes physician exposure to radiation during StabiliT Bone Cement delivery
  • Ultra-high viscosity StabiliT Bone Cement with extended working time

*>85% of RF-TVA procedures to date have used the unipedicular technique to enter the vertebra1

Explore Clinical Alternatives to Kyphoplasty:


The StabiliT® Vertebral Augmentation System is intended for percutaneous delivery of StabiliT® Bone Cement in vertebral augmentation (kyphoplasty) procedures in the treatment of pathological fractures of the vertebrae. Painful vertebral compression fractures may result from osteoporosis, benign lesions (hemangioma), and malignant lesions (metastatic cancers, myeloma).

As with most surgical procedures, kyphoplasty procedures using the StabiliT System (also called Radiofrequency-Targeted Vertebral Augmentation, or RF-TVA) involve risks, some of which may be serious or even fatal. Patients undergoing RF-TVA are subject to risks associated with surgery including, but not limited to, complications from anesthesia/sedation as well as bleeding, bruising, pain, infection, blood clots, myocardial infarction, cardiac arrest, stroke, pulmonary embolism, as well as damage to normal tissue, nerves, the spinal cord or other structures, which could result in injuries, including paralysis. Not every patient is a good candidate for RF-TVA. The StabiliT System is contraindicated for patients with coagulation disorders, severe pulmonary insufficiency, and certain spinal conditions, or patients who are sensitive to components of StabiliT Bone Cement.